Coke still not selling the strategy

Coke remains constrained by its strategic changes and the competition in soft beverages.

Coke
Source: Bloomberg

The Australian business remains under pressure in the supermarket price wars, leading to price deflation. This remains the core concern for both margins and growth.

There are three reasons I remain bearish on CCL:

Firstly, the strategic review is unlikely to yield any major efficiency in the interim, considering the strong performance of CCL in the past. Material cost reductions are unlikely because the company is already operationally efficient. Further declines here may actually impact revenue.

Secondly, CCL operates at an approximate 46% premium to its competitors. A price squeeze will remain a major detractor.

Finally, guidance remains broadly flat for the core Australian division, while its volatile Indonesian and Papua New Guinean markets have a growth profile of 8%. However, this is due to the alcoholic beverage division – something the core Australian market does not have exposure too.

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.

Find articles by analysts